[ad_1]
Moderna Inc.’s stock fell 6.4% Wednesday, after the company said that its respiratory syncytial virus, or RSV, shot showed 50% efficacy in preventing the illness after 18 months.
[ad_2]
Source link
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...
Investors will measure the response to this week's selloff, which came at a time when markets are entering a strong...
Tesla CEO and X owner Elon Musk gestures behind protective glass during a rally for Republican presidential nominee and former...
Sam Altman Co-founder and CEO of OpenAI speaks during the Italian Tech Week 2024 at OGR Officine Grandi Riparazioni on...
A lone traveler makes his way past a nearly deserted TSA security screening area at Orlando International Airport ahead of...
© AlertsPicks.com
